Microglia in the spinal cord and neuropathic pain
- PMID: 26813032
- PMCID: PMC4718109
- DOI: 10.1111/jdi.12379
Microglia in the spinal cord and neuropathic pain
Abstract
In contrast to physiological pain, pathological pain is not dependent on the presence of tissue-damaging stimuli. One type of pathological pain - neuropathic pain - is often a consequence of nerve injury or of diseases such as diabetes. Neuropathic pain can be agonizing, can persist over long periods and is often resistant to known painkillers. A growing body of evidence shows that many pathological processes within the central nervous system are mediated by complex interactions between neurons and glial cells. In the case of painful peripheral neuropathy, spinal microglia react and undergo a series of changes that directly influence the establishment of neuropathic pain states. After nerve damage, purinergic P2X4 receptors (non-selective cation channels activated by extracellular adenosine triphosphate) are upregulated in spinal microglia in a manner that depends on the transcription factors interferon regulatory factor 8 and 5, both of which are expressed in microglia after peripheral nerve injury. P2X4 receptor expression on the cell surface of microglia is also regulated at the post-translational level by signaling from CC chemokine receptor chemotactic cytokine receptor 2. Furthermore, spinal microglia in response to extracellular stimuli results in signal transduction through intracellular signaling cascades, such as mitogen-activated protein kinases, p38 and extracellular signal-regulated protein kinase. Importantly, inhibiting the function or expression of these microglial molecules suppresses the aberrant excitability of dorsal horn neurons and neuropathic pain. These findings show that spinal microglia are a central player in mechanisms for neuropathic pain, and might be a potential target for treating the chronic pain state.
Keywords: Microglia; Painful diabetic neuropathy; Purinergic receptors.
Figures
Similar articles
-
P2X4 receptors and neuropathic pain.Front Cell Neurosci. 2013 Oct 28;7:191. doi: 10.3389/fncel.2013.00191. Front Cell Neurosci. 2013. PMID: 24191146 Free PMC article. Review.
-
Catestatin is involved in neuropathic pain mediated by purinergic receptor P2X4 in the spinal microglia of rats.Brain Res Bull. 2018 Sep;142:138-146. doi: 10.1016/j.brainresbull.2018.07.003. Epub 2018 Jul 21. Brain Res Bull. 2018. PMID: 30016729
-
Purinergic signaling in microglia in the pathogenesis of neuropathic pain.Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(4):174-182. doi: 10.2183/pjab.93.011. Proc Jpn Acad Ser B Phys Biol Sci. 2017. PMID: 28413195 Free PMC article. Review.
-
Neuron-microglia interaction by purinergic signaling in neuropathic pain following neurodegeneration.Neuropharmacology. 2016 May;104:76-81. doi: 10.1016/j.neuropharm.2015.08.042. Epub 2015 Aug 29. Neuropharmacology. 2016. PMID: 26327676 Review.
-
RhoA/ROCK pathway mediates p38 MAPK activation and morphological changes downstream of P2Y12/13 receptors in spinal microglia in neuropathic pain.Glia. 2015 Feb;63(2):216-28. doi: 10.1002/glia.22745. Epub 2014 Aug 14. Glia. 2015. PMID: 25130721
Cited by
-
Calcitonin gene-related peptide attenuated discogenic low back pain in rats possibly via inhibiting microglia activation.Heliyon. 2024 Feb 7;10(3):e25906. doi: 10.1016/j.heliyon.2024.e25906. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38371980 Free PMC article.
-
Impact of inflammation and Treg cell regulation on neuropathic pain in spinal cord injury: mechanisms and therapeutic prospects.Front Immunol. 2024 Jan 29;15:1334828. doi: 10.3389/fimmu.2024.1334828. eCollection 2024. Front Immunol. 2024. PMID: 38348031 Free PMC article. Review.
-
Macrophages and microglia in inflammation and neuroinflammation underlying different pain states.Med Rev (2021). 2023 Nov 1;3(5):381-407. doi: 10.1515/mr-2023-0034. eCollection 2023 Oct. Med Rev (2021). 2023. PMID: 38283253 Free PMC article.
-
Glial cell alterations in diabetes-induced neurodegeneration.Cell Mol Life Sci. 2024 Jan 18;81(1):47. doi: 10.1007/s00018-023-05024-y. Cell Mol Life Sci. 2024. PMID: 38236305 Free PMC article. Review.
-
Microglia role in the pain phenomenon.Rev Assoc Med Bras (1992). 2023 Dec 22;70(1):e20230891. doi: 10.1590/1806-9282.20230891. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 38126413 Free PMC article. No abstract available.
References
-
- Baron R. Mechanisms of disease: neuropathic pain–a clinical perspective. Nat Clin Pract Neurol 2006; 2: 95–106. - PubMed
-
- Bastyr EJ 3rd, Price KL, Bril V. Development and validity testing of the neuropathy total symptom score‐6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther 2005; 27: 1278–1294. - PubMed
-
- Vinik AI, Suwanwalaikorn S, Stansberry KB, et al Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 1995; 18: 574–584. - PubMed
-
- Calcutt NA. Experimental models of painful diabetic neuropathy. J Neurol Sci 2004; 220: 137–139. - PubMed
-
- Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959–1964. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
